These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 24472740

  • 21. Corticotropin releasing factor receptor 1 antagonist differentially inhibits freezing behavior and changes gamma-aminobutyric acidergic activity in the amygdala in low- and high-anxiety rats.
    Skorzewska A, Wislowska-Stanek A, Lehner M, Turzynska D, Sobolewska A, Krzascik P, Plaznik A.
    J Physiol Pharmacol; 2017 Feb; 68(1):35-46. PubMed ID: 28456768
    [Abstract] [Full Text] [Related]

  • 22. Facilitation of 5-HT(2A/2C)-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze.
    da Silva ES, Poltronieri SC, Nascimento JO, Zangrossi H, Viana MB.
    Behav Brain Res; 2011 Jan 20; 216(2):692-8. PubMed ID: 20883726
    [Abstract] [Full Text] [Related]

  • 23. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L, Liu D, Ceng X, Ma L.
    Eur J Neurosci; 2000 Dec 20; 12(12):4398-404. PubMed ID: 11122350
    [Abstract] [Full Text] [Related]

  • 24. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
    Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ.
    J Pharmacol Exp Ther; 2000 Aug 20; 294(2):588-97. PubMed ID: 10900236
    [Abstract] [Full Text] [Related]

  • 25. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety.
    Takahashi LK, Ho SP, Livanov V, Graciani N, Arneric SP.
    Brain Res; 2001 Jun 01; 902(2):135-42. PubMed ID: 11384606
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY, van Leeuwen ML, Westphal KG, Olivier B, Groenink L.
    Neuroscience; 2011 Jan 26; 173():82-92. PubMed ID: 21093544
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
    Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong ML, Chrousos GP, Webster E, Gold PW.
    Endocrinology; 1999 Jan 26; 140(1):79-86. PubMed ID: 9886810
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Traumatic Stress Promotes Hyperalgesia via Corticotropin-Releasing Factor-1 Receptor (CRFR1) Signaling in Central Amygdala.
    Itoga CA, Roltsch Hellard EA, Whitaker AM, Lu YL, Schreiber AL, Baynes BB, Baiamonte BA, Richardson HN, Gilpin NW.
    Neuropsychopharmacology; 2016 Sep 26; 41(10):2463-72. PubMed ID: 27013358
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Activation of corticotropin-releasing factor receptors from the basolateral or central amygdala increases the tonic immobility response in guinea pigs: an innate fear behavior.
    Donatti AF, Leite-Panissi CR.
    Behav Brain Res; 2011 Nov 20; 225(1):23-30. PubMed ID: 21741994
    [Abstract] [Full Text] [Related]

  • 38. Evidence of lasting dysregulation of neuroendocrine and HPA axis function following global cerebral ischemia in male rats and the effect of Antalarmin on plasma corticosterone level.
    de la Tremblaye PB, Raymond J, Milot MR, Merali Z, Plamondon H.
    Horm Behav; 2014 Mar 20; 65(3):273-84. PubMed ID: 24444675
    [Abstract] [Full Text] [Related]

  • 39. Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity.
    Myers DA, Gibson M, Schulkin J, Greenwood Van-Meerveld B.
    Behav Brain Res; 2005 Jun 03; 161(1):39-44. PubMed ID: 15904708
    [Abstract] [Full Text] [Related]

  • 40. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF.
    Psychopharmacology (Berl); 2002 Mar 03; 160(2):113-21. PubMed ID: 11875628
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.